SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q2 2023
Institutional positions in SAB Biotherapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −1 vs. Q1 2023
- Shares held
- 3.96M
- +87.8K (+2.3%) vs. Q1 2023
- Total value
- $3.28M
- +$1.58M (+92.2%) vs. Q1 2023
- New holders
- 4
- 7 more added
- Sold out
- 5
- 4 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 962,738 | $799.1K | 0.00% | +261,154+37.2% | Added |
| First PREMIER Bank | 807,535 | $670.0K | 0.19% | 00.0% | Unchanged |
| Veritable, L.P. | 506,513 | $420.4K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 300,529 | $249.4K | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 277,777 | $230.6K | 0.00% | 00.0% | Unchanged |
| Institutional & Family Asset Management, LLC | 192,027 | $159.4K | 0.03% | +42,253+28.2% | Added |
| Bridgeway Capital Management, LLC | 84,000 | $69.7K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 81,241 | $67.4K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 73,470 | $61.0K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 69,000 | $57.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 54,400 | $45.0K | 0.00% | +54,400 | New |
| BlackRock Inc. | 52,643 | $43.7K | 0.00% | −57,370−52.1% | Reduced |
| Silver Oak Securities, Inc | 51,891 | $43.0K | 0.01% | 00.0% | Unchanged |
| Peapack Gladstone Financial Corp | 52,296 | $43.0K | 0.00% | +52,296 | New |
| Creative Planning | 47,518 | $39.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 44,476 | $36.9K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 36,200 | $30.0K | 0.00% | +36,200 | New |
| Virtu Financial LLC | 24,897 | $21.0K | 0.00% | +9,883+65.8% | Added |
| Two Sigma Investments, LP | 25,094 | $20.8K | 0.00% | +25,094 | New |
| LGL Partners, LLC | 23,000 | $19.1K | 0.00% | 00.0% | Unchanged |
| Brookstone Capital Management | 21,755 | $18.6K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 21,000 | $17.4K | 0.00% | +10,000+90.9% | Added |
| Advisor Group Holdings, Inc. | 18,896 | $15.7K | 0.00% | −200−1.0% | Reduced |
| Morgan Stanley | 17,306 | $14.4K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 16,238 | $13.5K | 0.00% | 00.0% | Unchanged |
| Strategic Financial Concepts, LLC | 15,027 | $12.5K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 14,545 | $12.1K | 0.00% | −1,517−9.4% | Reduced |
| Nadler Financial Group, Inc. | 13,750 | $11.4K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 12,865 | $10.7K | 0.00% | −574−4.3% | Reduced |
| 1st Source Bank | 10,000 | $8.30K | 0.00% | 00.0% | Unchanged |
| Baird Financial Group, Inc. | 10,000 | $8.30K | 0.00% | 00.0% | Unchanged |
| Elgethun Capital Management | 9,935 | $8.25K | 0.00% | +2,894+41.1% | Added |
| Royal Bank of Canada | 5,368 | $4.00K | 0.00% | +548+11.4% | Added |
| Gs Investments, Inc. | 2,000 | $1.66K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 881 | $731 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 500 | $415 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 247 | $205 | 0.00% | +60+32.1% | Added |
| GWM Advisors LLC | 145 | $120 | 0.00% | 00.0% | Unchanged |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −177,659−100.0% | Sold out |
| Meteora Capital, LLC | 0 | $0 | 0.00% | −134,524−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −28,400−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −6,679−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −54−100.0% | Sold out |